Respiratory Compromise as a New Paradigm
Acute respiratory compromise refers to a condition characterised by a deterioration in respiratory function with a high likelihood of rapid progression to respiratory failure and death. It is thus important to identify patients who are at risk of respiratory compromise.
See Also: Mechanical Ventilation: Which Patients Benefit from High PEEP?
This article focuses on hospitalised patients who are at high risk for respiratory failure or death and for whom these complications could be avoidable. Identifying patients who are in respiratory compromise or in whom respiratory compromise is worsening is a very important component of in-patient hospital care. It is thus important to implement appropriate interventions that could avoid catastrophic events.
This particular monograph is based on discussions that emerged during a workshop organised by the National Association for the Medical Direction of Respiratory Care (NAMDRC), it was highlighted that it was important to address the unmet needs of respiratory compromise from a clinical practice perspective. Different subsets of respiratory compromise were identified in order to facilitate early detection and useful intervention to prevent respiratory failure. Some common pathophysiological mechanisms that were identified include impaired control of breathing, impaired airway protection, parenchymal lung disease, increased airway resistance, hydrostatic pulmonary oedema and right-ventricular failure.
Non-respiratory conditions can also place patients at risk for respiratory failure and death. These include procedural sedation and other anesthetic approaches. Postoperative patients may be susceptible to respiratory failure due to opiate-induced respiratory depression and immobility-induced pulmonary embolus or atelectasis. In addition, neurological impairment can also increase the risk for respiratory failure from reduced mobility or altered ventilatory control mechanisms.
While respiratory compromise can be a chronic stable condition, the focus of this discussion is on respiratory compromise in the acute environment. Patients in acute care hospitals are especially at risk for developing respiratory compromise. Data suggests that respiratory failure requiring emergency mechanical ventilation occurs in over 44,000 patients per year in the U.S. The NSQIP reports that 1.03% of all surgical patients require an unplanned intubation post-operatively.
Patients who are hospitalised with respiratory illness are also known to have higher death rates as compared to those hospitalised for other common conditions. Development of in-hospital respiratory failure is associated with a mortality of nearly 40%. In-hospital deaths in patients with respiratory failure are twice as high as for myocardial infarction and much higher than for cancer, stroke, CHF and renal failure.
It is important to recognise respiratory compromise on the basis of both severity and risk and it is critical to develop preventive strategies and systems to identify respiratory compromise changes early in order to help prevent respiratory failure and death. By increasing attention, observation and therapeutics, it may be possible to improve survival in deteriorating patients.
Effective prevention and early detection and intervention for respiratory compromise could be more easily accomplished by an understanding of the various mechanisms by which respiratory homeostasis is maintained and also by identifying mechanisms by which it deteriorates. Classifying acutely ill respiratory patients into the right categories may help in selecting the most effective screening and monitoring strategies that would be most appropriate for that particular patient's pathophysiology.
Source: Respiratory Care
Published on : Wed, 5 Apr 2017
Print as PDF
NovaPort cannulas: The safe access to the vascular system. NovaPort® twin double lumen cannulas are specifically developed for veno-venous vascular access. NovaPort one single lumen cannulas are specifically developed for the percutaneous connection (KU)...
The technical and clinical reference standard for all B·R·A·H·M·S PCT assays. All clinical cut-offs and algorithms were developed based on B·R·A·H·M·S PCT sensitive KRYPTOR. Homogeneous immunoassay for the quantitative d
17 critical parameters from a blood sample as small as 45 µL Not available in the US When the sample is small but your diagnostic needs are big, the ABL90 FLEX PLUS blood gas analyzer provides critical insights with a turnaround time of less than...
Patient Dedicated Arterial Blood Gas Analyzer Frequent measurement of arterial blood samples is an important component in the effective management of patients in the critical care environment, particularly those that are unstable. Point of care or...